Newsfiscal.ai
Lyell Immunopharma to Present Updated Ronde-Cel Clinical Data at ASH 2026
· Published
Article summary
Lyell Immunopharma announced that two abstracts featuring positive updated clinical data for its ronde-cel therapy have been accepted for presentation at the 68th ASH Annual Meeting.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…